Home About Us Members Register Brochure Events Calendar Management Center Contact Us Chinese WCC2008 WCC2009  
 

 
  Schedule

BIT’s 3rd Annual World Congress of Cancer 2010, Singapore
Theme: We are One Family against Cancers
Time: June 22-25, 2010
Venue: Singapore EXPO, Singapore

Program Schedule

June 21, 2010 (Monday)

Time

Program

Place

08:00-18:00

Registration

Lobby, 1F, EXPO

June 22, 2010 (Tuesday)

Time

Program

Place

09:00-09:30

Opening Ceremony

Conference Hall, 2F

09:35-11:15

Keynote Forum

Conference Hall, 2F

12:00-13:00

Luncheon

Dinning Area, 1F

13:30-16:40

Track 1-1: Breast Cancer, Ovarian and Cervical Cancer (Part I)

Conference Hall A, 2F

13:30-15:10

Track 1-2: Prostate Cancer

Conference Hall E, 2F

13:30-17:05

Track 1-4: Nuclear Oncology-Diagnosis  and Therapy

Conference Hall B, 2F

13:10-17:25

Track 2-1: Cancer Epidemiology, Biostatistics and Prevention

Conference Hall C, 2F

13:30-16:45

Track 2-2: Molecular and Cell Oncology (Part I)

Conference Hall D, 2F

15:25-17:05

Track 2-2: Molecular and Cell Oncology (Part II)

Conference Hall E, 2F

13:30-15:45

Track 3-1: Stem Cell in Cancers

Conference Hall F, 2F

15:45-16:25

Track 3-2: RNA Technologies in Cancer Research

Conference Hall F, 2F

13:30-14:20

Track 4-1: Functional Genomics in Cancer Drug Discovery and Development

Conference Hall G, 1F

14:20-16:15

Track 4-2: Anticancer Drug Resistance and New Molecule Searching

Conference Hall G, 1F

13:30-16:05

Track 5-1: Cancer Biomarkers, Molecular Diagnostics, Blood Tests, and Biopsy

Conference Hall H, 1F

16:05-17:05

Track 5-2: Cancer Pathology and Imaging: From Biochemical Analysis to
Diagnostic Tool

Conference Hall H, 1F

18:30-20:30

Welcome Banquet

Bliss Garden Restaurant, 2F


June 23, 2010 (Wednesday)

Time

Program

Place

08:30-10:10

Track 1-5: Breast Cancer, Ovarian and Cervical Cancer (Part II)

Conference Hall A, 2F

10:25-12:05

Track 1-6: Pediatric Oncology

Conference Hall A, 2F

08:30-11:05

Track 2-3: Cancer Genomics, Genetics, Epigenetics and System Biology

Conference Hall B, 2F

11:05-11:45

Track 2-4: Hematology-Oncology

Conference Hall B, 2F

11:25-12:05

Track 3-3: Gene, Tissue Chips, Lab-On-Chip and Microfluidics

Conference Hall C, 2F

10:45-11:25

Track 4-3: Neuro-oncological Cancer Drug Discovery

Conference Hall C, 2F

08:30-09:10

Track 5-3: Cancer Genetic Screening and Prognosis

Conference Hall C, 2F

09:10-10:45

Track 5-4: Nuclear Medicine and Diagnosis

Conference Hall C, 2F

08:30-09:50

Track 6-1: Clinical Lung Cancer, Diagnostics and Treatment

Conference Hall F, 2F

09:50-11:45

Track 6-2: Molecular Epidemiology, Pathology and Prevention

Conference Hall F, 2F

10:45-12:05

Track 6-3: Molecular Profiling of Lung Cancer

Conference Hall D, 2F

08:30-09:30

Track 7-1: Acute Symptom Care Oncology Nursing & Quality Care

Conference Hall G, 1F

June 23, 2010 (Wednesday)

Time

Program

Place

08:30-10:45

Track 7-2:   Palliative Care, Psycho -Oncology, Nutritional Protection, Pain
Management

Conference Hall D, 2F

09:30-10:30

Track 8-1:   Advances In Cancer Screening and Monitoring

Conference Hall G, 1F

08:30-10:45

Track 8-2:   Botanical Medicine for Cancers in Clinical Practice

Conference Hall E, 2F

10:45-11:50

Track 8-3:   Nutritional Oncology and Food -borne Carcinogens

Conference Hall E, 2F

12:00-13:00

Luncheon

Dinning Area, 1F

13:30-16:45

Track 1-3:   Colorectal and Colon Cancers

Conference Hall A, 2F

13:30-14:10

Track 1-7:   Practical Chemotherapy and Anticancer Drug -Drug Interactions

Conference Hall B, 2F

14:10-15:10

Track 1-8:   Oesophageal and Gastrointestinal Cancers

Conference Hall B, 2F

15:25-17:05

Track 1-9:   Clinical Oncology

Conference Hall B, 2F

13:30-15:10

Track 1-10: Tumor Pathology

Conference Hall H, 1F

13:30-14:10

Track 2-5:   Tumor Virology

Conference Hall C, 2F

13:30-16:05

Track 3-4:   Proteomics in Cancer Research

Conference Hall D, 2F

14:10-15:30

Track 3-5:   PET in Oncology

Conference Hall C, 2F

13:30-15:10

Track 4-4:   New Cancer Biomarkers as Drug Targets

Conference Hall E, 2F

15:30-16:20

Track 4-5:   Anticancer Drugs Targeting Protein Kinase Inhibitors

Conference Hall C, 2F

13:30-17:05

Track 4-6:   Anticancer Drugs Targeting Signalling Pathways and Regulators

Conference Hall F, 2F

15:25-17:05

Track 4-7:   Inhibition of Metastasis to Vascular Targeting and
Anti-Angiogenesis

Conference Hall E, 2F

13:30-14:10

Track 5-5:   Immunohistochemical  Diagnosis of Cancer

Conference Hall G, 1F

14:10-15:10

Track 5-6:   DNA Level in Blood and Stool in Cancer Diagnosis

Conference Hall G, 1F

15:25-15:45

Track 7-3:   Cancer Epidemiology, Public Healthcare, and Reimbursement
Policy

Conference Hall G, 1F

15:45-17:05

Track 8-4:   Cancer Rehabilitation, Nutrition and Complementary Therapy

Conference Hall G, 1F

June 24, 2010 (Thursday)

Time

Program

Place

10:50-12:05

Track 1-11: Practical Gynecologic Oncology

Conference Hall A, 2F

08:30-10:50

Track 1-12: Head, Nasopharyngeal, Neck, Thyroid and Brain Cancers

Conference Hall A, 2F

08:30-09:50

Track 1-13: Rectum, Liver, Cholecyst and Pancreatic Cancer

Conference Hall B, 2F

08:30-09:10

Track 1-14: Lymphoma and Melanoma

Conference Hall C, 2F

09:10-11:25

Track 2-6:   Tumor Immunology and Immunotherapy

Conference Hall C, 2F

08:30-12:05

Track 2-7:   Cancer/Tumor Adhesion, Migration, Invasion, and Metastasis

Conference Hall D, 2F

09:20-10:10

Track 3-6:   Cancer Digital Imaging Technologies

Conference Hall E, 2F

09:50-11:50

Track 4-8:   Apoptotic Inducers, Targeting Apoptosis Signaling Pathways and
their Mediators

Conference Hall B, 2F

08:30-09:20

Track 4-9:   Anticancer Drug Discovery Targeting Telomerase

Conference Hall E, 2F

10:25-11:45

Track 4-10: New Anticancer Drug Discovery Targeting Cell Life Cycle

Conference Hall E, 2F

11:45-12:05

Track 4-11: Photodynamic Cancer Therapeutic Development

Conference Hall E, 2F

10:25-11:05

Track 4-12: Anticancer Gene Therapy

Conference Hall F, 2F

June 24, 2010 (Thursday)

Time

Program

Place

08:30-10:10

Track 4-21: Multi-modal Attacks on Cancer: Focal Therapies as Immune
Promoters

Conference Hall F, 2F

11:05-12:05

Track 5-7:   Robotics and Tumor Mini -invasive Therapy

Conference Hall F, 2F

08:30-11:25

Track 5-8:   Radiotherapy and Medical Device Therapy for Cancer

Conference Hall G, 1F

08:30-09:50

Track 6-4:   NSCLC & SCLC and Interventions

Conference Hall H, 1F

09:50-11:45

Track 6-5:   Chemotherapy for Lung Cancer

Conference Hall H, 1F

12:00-13:00

Luncheon

Dinning Area, 1F

13:30-14:30

Track 1-15: Skin Cancer and Sarcomas

Conference Hall A, 2F

13:30-15:10

Track 1-16: Leukemia and Myelodysplasia

Conference Hall B, 2F

14:30-16:05

Track 1-17: Chest, Bone, and Soft Tissue Cancers

Conference Hall A, 2F

16:05-16:45

Track 1-18: Clinical Progress in Urology, Kidney/Renal Cancers

Conference Hall B, 2F

13:30-15:10

Track 2-8:   Tumor Microenvironmen t and Therapy

Conference Hall C, 2F

15:25-16:45

Track 2-9:   Chromatin Regulation and Cancers

Conference Hall C, 2F

15:25-16:05

Track 3-7:   Laparoscopic Techniques in Uro -Oncology and Digestive System
Cancer

Conference Hall B, 2F

13:30-15:10

Track 4-13: Stem Cells and Cancer Cell Therapy

Conference Hall D, 2F

15:25-16:40

Track 4-14: RNAi, siRNA and mRNA Based Anticancer Drug Discovery

Conference Hall D, 2F

13:30-14:10

Track 4-15: Therapeutic Antibodies

Conference Hall E, 2F

14:10-15:10

Track 4-16: Therapeutic Cancer Vaccines

Conference Hall E, 2F

15:25-16:45

Track 4-17: Medicinal Chemistry in Anticancer Drug Discovery

Conference Hall E, 2F

13:30-15:30

Track 5-9:   Cancer Surgery, Interventional Therapy and Symptom Management

Conference Hall F, 2F

15:30-16:10

Track 5-10: Clinical Update on Combination Cancer Therapy

Conference Hall F, 2F

16:10-17:10

Track 6-6:   Translational Research and Clinical Trials

Conference Hall F, 2F

June 25, 2010 (Friday)

Time

Program

Place

10:25-11:15

Track 2-10: Bioinformatics and Med-informatics in Cancer Research

Conference Hall G, 1F

08:30-09:50

Track 2-11: Mechanisms of Resistance in Cancer Cells

Conference Hall G, 1F

09:10-10:45

Track 2-12: Cancer Metastases Research

Conference Hall H, 1F

08:30-09:10

Track 2-13: Surgical Oncology

Conference Hall H, 1F

10:45-11:35

Track 4-18: Pharmacology, ADMET and Anticancer Drug Discovery

Conference Hall H, 1F

08:30-10:10

Track 4-19: Nanotechnology and Novel Drug Delivery Systems

Conference Hall J, 1F

11:15-11:40

Track 4-20: Innovative Designs of Phase I/II Trials, Regulatory Issues and
Translational Research

Conference Hall G, 1F

12:00-13:00

Luncheon

Dinning Area, 1F

 



© 2008-2010 All right reserved for BIT Conferences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629